Inspire Veterinary Partners Faces Delisting Notice

TL;DR

IVP got a delisting notice - stock might be delisted.

AI Summary

Inspire Veterinary Partners, Inc. filed an 8-K on November 17, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, incorporated in Nevada, is based in Virginia Beach, VA, and its principal executive offices are located at 780 Lynnhaven Parkway, Suite 400.

Why It Matters

This filing indicates potential issues with Inspire Veterinary Partners' compliance with stock exchange listing standards, which could lead to the company's shares being delisted.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading viability.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• November 17, 2025 (date) — Date of Report
• Nevada (jurisdiction) — State of Incorporation
• 001-41792 (identifier) — Commission File Number
• 85-4359258 (identifier) — I.R.S. Employer Identification No.
• 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Address of principal executive offices
• ( 757 ) 734-5464 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat

Filing Documents

• ea0265935-8k_inspire.htm (8-K) — 25KB
• 0001213900-25-111267.txt ( ) — 189KB
• ivp-20251117.xsd (EX-101.SCH) — 3KB
• ivp-20251117_lab.xml (EX-101.LAB) — 33KB
• ivp-20251117_pre.xml (EX-101.PRE) — 22KB
• ea0265935-8k_inspire_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 13, 2025, Inspire Veterinary Partners, Inc. (the "Company") received a notice letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, based upon the closing bid price of the Company's common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Further, the Notice stated that, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company was not eligible for any compliance period specified in Rule 5810(c)(3)(A) due to the fact that the Company has effected a reverse stock split over the prior one-year period and has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one. The Notice stated that the Company's securities will be suspended from trading on The Nasdaq Capital Market at the opening of business on November 24, 2025, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission, which will remove the Company's securities from listing and registration on Nasdaq, unless the Company requests an appeal of such determination to Nasdaq's Hearings Panel (the "Panel") by November 20, 2025. The Company intends to request a hearing before the prescribed date, which request will stay any further suspension or delisting action by Nasdaq pending the ultimate conclusion of the hearing process. There can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance and thereafter maintain its listing on Nasdaq. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 17, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR